Aclaris Therapeutics, Inc. (ACRS)
3.52
+0.90
(+34.35%)
USD |
NASDAQ |
Jan 20, 11:25
Aclaris Therapeutics Total Assets (Quarterly): 175.53M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Puma Biotechnology, Inc. | 202.86M |
| Nephros, Inc. | 13.25M |
| Prelude Therapeutics, Inc. | 94.76M |
| Vivos Therapeutics, Inc. | 25.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.43M |
| Shareholders Equity (Quarterly) | 120.10M |
| Debt to Equity Ratio | 0.0187 |
| Current Ratio | 3.925 |
| Net Debt Paydown Yield | 0.06% |